GlobeNewswire

YPO Announces the 2018 Global Innovation Award Winners

Dela

Honoring Global Leaders Initiating Innovative, Transformative and Inspirational Breakthroughs 

DALLAS, May 10, 2018 (GLOBE NEWSWIRE) -- YPO, the premier chief executive leadership organization in the world, announced the winners of the Global Innovation Awards as a part of its third annual YPO Innovation Week. The Global Innovation Awards honors those YPO members who have initiated breakthrough innovations that inspire positive transformation.

In addition to recognizing the top innovators from among more than 25,000 YPO members across 130 countries, the Global Innovation Awards also honor Africa's top innovator and the top young adult innovator, who is a child of YPO member (ages 17-29).

"Each year, YPO has this amazing opportunity to honor and highlight these distinguished innovators who are making an indelible mark around the world. The Global Innovation Awards highlight those who are leading the way in creating forward-thinking companies and significant opportunities now and for future generations," said Keith Alper, Chair of YPO Innovation Week.

During May, the 2018 YPO Innovation Week will connect influential entrepreneurs, innovators and thought leaders to exchange ideas about inspiration, breakthroughs and transformation through more than 50 signature events, live two-way interactive video casts and livestream events around the world. YPO announced the top African innovator at Africa Ignite in Nairobi, Kenya, and the Global Innovation Award winner in New York City.

2018 Global Innovation Award Winners

Global Innovation Award - Harjit Gill, X-Halo
Harjit Gill is the CEO of X-Halo, the world's first device to detect the early onset of respiratory diseases before any signs of symptoms. Connected to a smartphone, the device is the only one to give early warnings of disease and track lung health by measuring breath temperature.

Through the device, once signs are detected, patients can implement lifestyle changes and medication options to manage any potential issues at an affordable cost at home.

Global Innovation Award - Africa Top Innovator - Yariv Cohen, Ignite Power
Yariv Cohen is the CEO of Ignite Power, a Pan-African developer and financier of safe clean energy solutions. Of these solutions is a solar system for rural homes that integrates with mobile money for a pay-as-you-use energy and leasing model costing as little as USD4 per month.

Ignite Power has connected nearly 500,000 people to safe solar power and projects to reach 10 million by 2021.

Global Innovation Award - YPO Next Generation - Leslie Lim, Cicil 
Leslie Lim is the Co-Founder of Cicil, a Google launchpad accelerator startup focused on providing financial access to the underserved Indonesian university student segment. Cicil provides micro loans to students, helping them in a number of ways including financing laptops and tablets, sports equipment and more.

"Congratulations to the 2018 Global Innovation Award honorees as they highlight the innovation and breadth of talent of the global YPO network," said Scott Mordell, CEO of YPO. "These innovators are accelerating what's next and leading the way for the future."

Finalists
The top finalists for the YPO Global Innovation Awards include:

Jerry Callahan, Founder and CEO of Heatworks
Jerry Callahan is the inventor of Ohmic Array Technology, which combines an array of graphite electrodes with a digital control mechanism, providing a pure and effective method of heating water using water as the heating element instead of metallic heating elements.

Nicolas Durand, CEO and Founder of Abionic
Nicolas Durand is the CEO and Founder of Abionic, which has developed the abioSCOPE, the world's most rapid diagnostic platform based on a drop of blood to improve medical diagnosis at point-of-care.

George Kurtz, President, CEO and Co-Founder of CrowdStrike
George Kurtz is the President, CEO and Co-Founder of CrowdStrike, a cybersecurity technology company highly recognized for its cloud-driven approach to stopping breaches. CrowdStrike's technology - the Falcon platform - has established a new standard in helping organizations stop breaches, extending beyond malware to prevent advanced targeted attacks regardless of their origin or technique.

Sunil Lalvani, Managing Director of Binatone Lifestyle Ltd.
Sunil Lalvani founded Project Maji to tackle the global water challenge by designing and developing solar-powered water kiosks across rural communities in sub-Saharan Africa to provide safe drinking water. Currently, Project Maji provides 15,000 people with clean water across 11 locations with the goal of expanding to one million people by 2025.

Christina Lomasney, President, CEO and Co-Founder of Modumetal, Inc.
Christina Lomasney is the President, CEO and Co-Founder of Modumetal, which manufactures a new class of nanolayered metals that are stronger, lighter and more durable than conventional metals and alloys. While derived from the same basic raw materials as conventional metals, Modumetal's nanolaminated alloys can be used almost anywhere metals and alloys are used today while providing significant performance improvements over conventional metals

Bob White, President and CEO of Entellus Medical, Inc
Bob White is the President and CEO of Entellus Medical, Inc, which has created the XprESS ENT Dilation System. The system, which has treated more than 200,000 to date, is used for the minimally invasive treatment of adult and pediatric patients with chronic and recurrent sinusitis. Patients treated with the system have experienced faster recovery, less bleeding, less use of prescription pain medication and fewer post-procedure debridements.

Lee Zheng, Owner of Smart Technologies and Investment Ltd. and Founder and CEO of PIN Genie
Lee Zheng is the owner of Smart Technologies and Investment and Founder and CEO of PIN Genie. PIN Genie is an innovation of PIN technology. This highly secure, peek-proof patented technology can be applied to devices that require the use of PIN, making it impossible for others to spy a PIN and providing more security and convenience for users.

About YPO Innovation Week

YPO Innovation Week is a series of more than 50 events conducted in over 30 countries throughout the world from 7-11 May 2018, featuring dynamic global innovators who will come together to share best-in-class business strategies as well as timely and relevant insights that are fueling innovation and shaping the future of global business over the next decade.

Through signature Innovation Week events, live two-way interactive video casts and livestream events, business leaders will learn how to keep pace with innovation trends on a global scale, innovate and disrupt industry practices, nurture and develop value-creating ideas across organizations and positively impact communities, industries and the world.

About YPO

The premier leadership organization of chief executives in the world.

YPO is the global platform for chief executives to engage, learn and grow. YPO members harness the knowledge, influence and trust of the world's most influential and innovative business leaders to inspire business, personal, family and community impact.

Today, YPO empowers more than 25,000 members in more than 130 countries, diversified among industries and types of businesses. Altogether, YPO member-run companies employ 16 million people and generate USD6 trillion in annual revenues.

Leadership. Learning. Lifelong. For more information, visit YPO.org.

Contact:
YPO 
Linda Fisk
Office: +1 972 629 7305 (United States)
Mobile: +1 972 207 4298 
press@ypo.org




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: YPO via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum